|Classification and external resources|
In thalassaemia, the disease is caused by the weakening and destruction of red blood cells. This is caused by mutant genes which affect how the body makes haemoglobin. Haemoglobin is the protein in red blood cells which carries oxygen. People with thalassaemia make less haemoglobin and fewer circulating red blood cells than normal, which results in mild or severe anemia.
Thalassaemia can cause significant complications, including pneumonia, iron overload, bone deformities and cardiovascular illness. However, this inherited disease of red blood cells gives a degree of protection against malaria, which is or was common in the regions where the trait is common. This selective survival advantage for carriers (known as heterozygous advantage) is responsible for keeping the mutation in populations way above its mutation rate. Carriers are heterozygous for the thalassaemia allele, meaning only one of their two alleles is mutant (abnormal). There are a number of different versiona of thalassaemia. Each one is caused by a mutation in a different position in the genome.
References[change | change source]
- Weatherall David J, Chapter 47. The Thalassemias: disorders of globin synthesis. In Lichtman MA et al. Williams Hematology. 8th ed. 
- Mayo Clinic. 
- HLA-matched sibling bone marrow transplantation for β-thalassemia major, Blood Journal, 3 February 2011
- HLA = Human leukocyte antigen, a key part of the immune system.